283 related articles for article (PubMed ID: 26232373)
1. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice.
Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W
Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373
[TBL] [Abstract][Full Text] [Related]
2. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton.
Jardí F; Laurent MR; Dubois V; Khalil R; Deboel L; Schollaert D; Van Den Bosch L; Decallonne B; Carmeliet G; Claessens F; Vanderschueren D
Mol Cell Endocrinol; 2017 Sep; 452():57-63. PubMed ID: 28504114
[TBL] [Abstract][Full Text] [Related]
3. Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations.
Donocoff RS; Teteloshvili N; Chung H; Shoulson R; Creusot RJ
Sci Rep; 2020 Sep; 10(1):15244. PubMed ID: 32943672
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen induction of Cre recombinase does not cause long-lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies.
Chucair-Elliott AJ; Ocanas SR; Stanford DR; Hadad N; Wronowski B; Otalora L; Stout MB; Freeman WM
Geroscience; 2019 Oct; 41(5):691-708. PubMed ID: 31493147
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Tamoxifen Induces Significant Bone Formation in Mice.
Xie Z; McGrath C; Sankaran J; Styner M; Little-Letsinger S; Dudakovic A; van Wijnen AJ; Rubin J; Sen B
JBMR Plus; 2021 Mar; 5(3):e10450. PubMed ID: 33778320
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
Kangas L; Härkönen P; Väänänen K; Peng Z
Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
[TBL] [Abstract][Full Text] [Related]
7. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
Xu J; Yao G; Ru Y; Xie S
Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
[TBL] [Abstract][Full Text] [Related]
8. Inducible Cre mice.
Feil S; Valtcheva N; Feil R
Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
[TBL] [Abstract][Full Text] [Related]
9. Standardizing protocols dealing with growth hormone receptor gene disruption in mice using the Cre-lox system.
Duran-Ortiz S; Bell S; Kopchick JJ
Growth Horm IGF Res; 2018; 42-43():52-57. PubMed ID: 30195091
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
Zhao J; Nassar MA; Gavazzi I; Wood JN
Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
[TBL] [Abstract][Full Text] [Related]
12. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice.
Hall ME; Smith G; Hall JE; Stec DE
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H253-60. PubMed ID: 21536850
[TBL] [Abstract][Full Text] [Related]
13. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.
Vasioukhin V; Degenstein L; Wise B; Fuchs E
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8551-6. PubMed ID: 10411913
[TBL] [Abstract][Full Text] [Related]
14. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance.
Baek WY; de Crombrugghe B; Kim JE
Bone; 2010 Apr; 46(4):920-8. PubMed ID: 20026264
[TBL] [Abstract][Full Text] [Related]
15. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis.
Denk F; Ramer LM; Erskine EL; Nassar MA; Bogdanov Y; Signore M; Wood JN; McMahon SB; Ramer MS
Acta Neuropathol Commun; 2015 Nov; 3():74. PubMed ID: 26610346
[TBL] [Abstract][Full Text] [Related]
17. Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation.
Hammad S; Othman A; Meyer C; Telfah A; Lambert J; Dewidar B; Werle J; Nwosu ZC; Mahli A; Dormann C; Gao Y; Gould K; Han M; Yuan X; Gogiashvili M; Hergenröder R; Hellerbrand C; Thomas M; Ebert MP; Amasheh S; Hengstler JG; Dooley S
Arch Toxicol; 2018 Aug; 92(8):2549-2561. PubMed ID: 29974145
[TBL] [Abstract][Full Text] [Related]
18. Oral and Injected Tamoxifen Alter Adult Hippocampal Neurogenesis in Female and Male Mice.
Smith BM; Saulsbery AI; Sarchet P; Devasthali N; Einstein D; Kirby ED
eNeuro; 2022; 9(2):. PubMed ID: 35387845
[TBL] [Abstract][Full Text] [Related]
19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
20. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
